Both in Pharmaceuticals
Geron vs Kura Oncology
Over the past year GERN returned −5.9% and KURA returned −7.8%; their daily moves had a correlation of 0.32.
GERN −5.9% KURA −7.8%Growth of $1, one year, split-adjusted
| Metric | GERN | KURA |
|---|---|---|
| Price | $1.20 | $9.22 |
| Market cap | $767.8M | $819.8M |
| Today | +2.14% | +1.49% |
| 1 month | −8.1% | −21.4% |
| 6 months | −23.4% | −5.8% |
| Year to date | −9.5% | −11.3% |
| 1 year | −2.8% | −9.0% |
| Revenue growth (YoY) | +17.2% | +36.5% |
| Gross margin | 83.9% | 98.8% |
| Net margin | −29.0% | −327.3% |
| P/E (TTM) | — | — |
| Price / sales | 3.8× | 10.6× |
| Net cash | $51.1M | $509.2M |
| Dividend yield | — | — |
| Volatility (60d) | 64.5% | 55.8% |
| Short % of float | 11.8% | 18.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).